reports
Medallion Financial Corp. Reports 2024 First Quarter Results
Medallion Financial Corp. Reports 2024 First Quarter Results NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- Medallion Financial Corp. (NASDAQ: MFIN, “Medallion” or the “Company”), a specialty finance company that originates and services loans in various consumer and commercial industries, along with offering loan origination services to fintech strategic partners, announced today its results for the quarter ended March 31, 2024. 2024 First Quarter Highlights Net income was $10.0 million, or $0.42 per share, compared to $15.4 million, or $0.67 per share, in the prior year quarter.$3.1 ...
Gibson Energy Announces Voting Results for Election of Board of Direct...
Gibson Energy Announces Voting Results for Election of Board of Directors CALGARY, Alberta, April 30, 2024 (GLOBE NEWSWIRE) -- Gibson Energy Inc. (TSX:GEI) ("Gibson" or the "Company") announced today the voting results for the election of directors at the Company’s hybrid annual general meeting of shareholders that was held on April 30, 2024. Voting Results Name of NomineeVotes For(%) ForVotes Withheld(%) WithheldJames M. Estey109,335,07399.49%559,3090.51%Douglas P. Bloom109,558,92999.69%335,4530.31%Judy E. Cotte109,533,38999.67%360,9930.33%Heidi L. Dutton109,807,31299.92%87,0700.08%Mari...
Progressive Announces Investor Relations Call
Progressive Announces Investor Relations Call MAYFIELD VILLAGE, OHIO, April 30, 2024 (GLOBE NEWSWIRE) -- As previously announced, The Progressive Corporation (NYSE: PGR) will host an Investor Relations conference call on Tuesday, May 7, 2024, beginning at 9:30 a.m. eastern time. This quarterly call, which will consist of both a conference call and audio-only webcast, is scheduled to last 60 minutes and will consist of a question-and-answer session with Tricia Griffith, our CEO, and John Sauerland, our CFO. Call-in participants will be able to ask questions via phone, however, webcast part...
Mondelēz International Reports Q1 2024 Results
Mondelēz International Reports Q1 2024 Results First Quarter Highlights Net revenues increased +1.4% driven by Organic Net Revenue1 growth of +4.2% with underlying Volume/Mix of -2.1%Diluted EPS was $1.04, down 31.6%; Adjusted EPS1 was $0.95, up +16.3% on a constant currency basisCash provided by operating activities was $1.3 billion, up $0.2 billion versus prior year; Free Cash Flow1 was $1.0 billion, up $0.1 billion versus prior yearReturn of capital to shareholders was $1.1 billion CHICAGO, April 30, 2024 (GLOBE NEWSWIRE) -- Mondelēz International, Inc. (Nasdaq: MDLZ) today reported ...
Medallion Bank Reports 2024 First Quarter Results and Declares Series ...
Medallion Bank Reports 2024 First Quarter Results and Declares Series F Preferred Stock Dividend SALT LAKE CITY, April 30, 2024 (GLOBE NEWSWIRE) -- Medallion Bank (Nasdaq: MBNKP, the “Bank”), an FDIC-insured bank providing consumer loans for the purchase of recreational vehicles, boats, and home improvements, along with loan origination services to fintech strategic partners, announced today its results for the quarter ended March 31, 2024. The Bank is a wholly owned subsidiary of Medallion Financial Corp. (Nasdaq: MFIN). 2024 First Quarter Highlights Net income of $14.5 million, compar...
Great Lakes Dredge & Dock Corporation Schedules Announcement of 2024 F...
Great Lakes Dredge & Dock Corporation Schedules Announcement of 2024 First Quarter Results HOUSTON, April 30, 2024 (GLOBE NEWSWIRE) -- Great Lakes Dredge & Dock Corporation (NASDAQ: GLDD) today announced that it will release the financial results for its three months ended March 31, 2024 on Tuesday, May 7, 2024 at 7:00 a.m. C.D.T. A conference call with the Company will be held the same day at 9:00 a.m. C.D.T. Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will be given a unique PIN to gain immediate ac...
Gulf Island Announces First Quarter 2024 Results Conference Call Date
Gulf Island Announces First Quarter 2024 Results Conference Call Date THE WOODLANDS, Texas, April 30, 2024 (GLOBE NEWSWIRE) -- Gulf Island Fabrication, Inc. (“Gulf Island” or the “Company”) (NASDAQ: GIFI), a leading steel fabricator and service provider to the industrial and energy sectors, today announced that it will report financial results for the first quarter 2024 after the market close on Tuesday, May 7, 2024. Gulf Island management will hold a conference call on Tuesday, May 7, 2024, at 4:00 p.m. Central Time (5:00 p.m. Eastern Time) to discuss the Company’s financial results. T...
Phillips Edison & Company Declares Monthly Dividend Distributions; Ann...
Phillips Edison & Company Declares Monthly Dividend Distributions; Announces Results of Annual Meeting of Stockholders CINCINNATI, April 30, 2024 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO”), one of the nation’s largest owners and operators of grocery-anchored neighborhood shopping centers, today announced that its Board of Directors declared monthly dividend distributions of $0.0975 per share of the Company’s common stock payable on June 4, 2024; July 2, 2024; and August 1, 2024 to stockholders of record as of May 15, 2024; June 17, 2024; and July 15, 2024,...
Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on ...
Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024 SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that it will report the Company’s first quarter 2024 financial results on Tuesday, May 7, 2024, after the close of the U.S. financial markets. About Aligos Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that wa...
CVRx Reports First Quarter 2024 Financial and Operating Results
CVRx Reports First Quarter 2024 Financial and Operating Results MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for the first quarter of 2024. Recent Highlights Total revenue for the first quarter 2024 was $10.8 million, an increase of 35% over the prior year quarterU.S. Heart Failure (HF) revenue for the first quarter of 20...
Barfresh to Host Business Update Call on May 15, 2024
Barfresh to Host Business Update Call on May 15, 2024 LOS ANGELES, April 30, 2024 (GLOBE NEWSWIRE) -- Barfresh Food Group Inc. (the “Company” or “Barfresh”) (Nasdaq: BRFH), a provider of frozen, ready-to-blend and ready-to-drink beverages, today announced that it will host a business update call on Wednesday, May 15, 2024 1:30 pm Pacific Time (4:30 pm Eastern Time). Listeners can dial (877) 407-4018 in North America, and international listeners can dial (201) 689-8471. A telephonic playback will be available approximately two hours after the call concludes and will be available through W...
Columbia Financial, Inc. Announces Financial Results for the First Qua...
Columbia Financial, Inc. Announces Financial Results for the First Quarter Ended March 31, 2024 FAIR LAWN, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- Columbia Financial, Inc. (the “Company”) (NASDAQ: CLBK), the mid-tier holding company for Columbia Bank ("Columbia") and Freehold Bank ("Freehold"), reported a net loss of $1.2 million, or $0.01 per basic and diluted share, for the quarter ended March 31, 2024, as compared to net income of $18.7 million, or $0.18 per basic and diluted share, for the quarter ended March 31, 2023. The net loss for the quarter ended March 31, 2024 reflected lower...
Inari Medical Reports First Quarter 2024 Financial Results
Inari Medical Reports First Quarter 2024 Financial Results IRVINE, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its first quarter ended March 31, 2024. First Quarter Financial and Recent Business Highlights Generated revenue of $143.2 million in Q1 of 2024, up 23.3% over the same quarter last year.GAAP operating loss was $17.2 million in Q1 of 2024, compared to a $5.3 million operat...
Myriad Genetics to Release First Quarter 2024 Financial Results on May...
Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024 Management will also participate in four upcoming investor healthcare conferences SALT LAKE CITY, April 30, 2024 (GLOBE NEWSWIRE) -- . (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will hold its first quarter earnings conference call on Tuesday, May 7, 2024 at 4:30pm ET. The company’s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company’s performance for the first...
Exagen to Announce First Quarter 2024 Results on May 13, 2024
Exagen to Announce First Quarter 2024 Results on May 13, 2024 CARLSBAD, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended March 31, 2024, before the market opens on Monday, May 13, 2024. John Aballi, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Chief Financial Officer, will host a conference call to review the Company’s results at 8:30 AM ET (5:30 AM PT). Interested parties may access the conference call by dialing (201) 389-0918 (U.S.) or (877) 407-0890 ...
Denny’s Corporation Reports Results for First Quarter 2024
Denny’s Corporation Reports Results for First Quarter 2024 SPARTANBURG, S.C., April 30, 2024 (GLOBE NEWSWIRE) -- Denny’s Corporation (the "Company") (NASDAQ: DENN), owner and operator of Denny's Inc. ("Denny's") and Keke's Inc. ("Keke's") today reported results for its first quarter ended March 27, 2024 and provided a business update on the Company’s operations. Kelli Valade, Chief Executive Officer, stated, "I am very pleased that our first quarter domestic same-restaurant sales and traffic outperformed both the family and casual dining segments, while overcoming the industry's tough o...
Dynagas LNG Partners LP Declares Cash Distribution on Its Series B Pre...
Dynagas LNG Partners LP Declares Cash Distribution on Its Series B Preferred Units ATHENS, Greece, April 30, 2024 (GLOBE NEWSWIRE) -- Dynagas LNG Partners LP (the “Partnership”) (NYSE: DLNG), an owner and operator of liquefied natural gas (“LNG”) carriers, today announced that its Board of Directors has declared a cash distribution of $0.69853375 per unit on its Series B Fixed to Floating Cumulative Redeemable Perpetual Preferred Units (the “Series B Preferred Units”) (NYSE: DLNG PR B) for the period from and including February 22, 2024 to and including May 21, 2024 (the “Distribution Per...
Clearway Energy, Inc. Announces CEO Transition and Reiterates 2024 Fin...
Clearway Energy, Inc. Announces CEO Transition and Reiterates 2024 Financial Guidance PRINCETON, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) (“Company”, “Clearway”) today announced that effective June 30, 2024, Chris Sotos will move on from his position as Clearway Energy, Inc.’s President and Chief Executive Officer (“CEO”) and resign from his role as a member of CWEN’s Board of Directors to pursue other opportunities. Craig Cornelius, who is currently the CEO of the Company’s sponsor, Clearway Energy Group (“Clearway Group”), will succeed Mr. Soto...
Predictive Oncology Announces Significant Progress with FluGen In the ...
Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine PITTSBURGH, April 30, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announces a collaboration with FluGen to bring a first-of-its-kind intranasal flu vaccine to market, as part of a $6.2 million Phase 2B grant awarded by the United States Department of Defense (DoD). “Predictive Oncology will play a critical role in helping to make our M2SR flu vaccine more stable and sustainable as we advance...
Bionano to Present at the RBC Capital Markets 2024 Global Healthcare C...
Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the RBC Capital Markets 2024 Global Healthcare Conference on May 15, 2024. Conference & Webcast Details Date:May 15, 2024Time:8:00 a.m. to 8:25 a.m. ETPresenter:Erik Holmlin, PhD, CEO of BionanoWebcast: A replay / recording of the session will be available following the conference through the Bionano website at for at leas...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.